v3.25.1
CONVERTIBLE DEBT
12 Months Ended
Dec. 31, 2024
Aspire Biopharma Inc [Member]  
CONVERTIBLE DEBT

NOTE 9 - CONVERTIBLE DEBT

 

As of December 31, 2024 and December 31, 2023, the Company had no outstanding convertible debt.